| Antidepressants and the risk of hemorrhagic stroke in the elderly: a nested case–control study W Schäfer, C Princk, B Kollhorst, T Schink Drug Safety 42, 1081-1089, 2019 | 17 | 2019 |
| Anticholinergic burden and fractures: a systematic review with methodological appraisal J Reinold, W Schäfer, L Christianson, F Barone-Adesi, O Riedel, FE Pisa Drugs & aging 37 (12), 885-897, 2020 | 11 | 2020 |
| Follow-up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years S Schwarz, W Schäfer, D Horenkamp-Sonntag, J Liebentraut, U Haug Clinical and Translational Gastroenterology 12 (1), e00279, 2021 | 10 | 2021 |
| How often are antidepressants prescribed off‐label among older adults in Germany? A claims data analysis W Schäfer, T Reinders, O Riedel, U Haug British Journal of Clinical Pharmacology 87 (4), 1778-1789, 2021 | 6 | 2021 |
| Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions W Schäfer, T Reinders, T Schink Vaccine 40 (14), 2168-2172, 2022 | 3 | 2022 |
| Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis J Reinold, W Schäfer, L Christianson, F Barone-Adesi, O Riedel, FE Pisa BMJ open 9 (8), e030205, 2019 | 3 | 2019 |
| Characterization of pregnancies exposed to St. John’s wort and their outcomes: A claims data analysis W Schäfer, N Wentzell, T Schink, U Haug Reproductive Toxicology 102, 90-97, 2021 | 2 | 2021 |
| German mammography screening program: adherence, characteristics of (non-) participants and utilization of non-screening mammography—a longitudinal analysis M Heinig, W Schäfer, I Langner, H Zeeb, U Haug BMC Public Health 23 (1), 1678, 2023 | 1 | 2023 |
| Time of Change: Health Effects of Motherhood FT Dehos, M Paul, W Schäfer, K Süss | | 2024 |
| Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study M Reilev, PB Jensen, LS Ranch, A Egeberg, K Furu, K Gembert, D Hagg, ... BMJ open 13 (2), e066057, 2023 | | 2023 |
| Utilization of antidepressants in vulnerable groups of patients: investigations using data from the German Pharmacoepidemiological Research Database (GePaRD) W Schäfer Universität Bremen, 2022 | | 2022 |
| Time trends in antidepressant use among women aged 45-75 in Germany W Schaefer, M Heinig, U Haug PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 186-186, 2022 | | 2022 |
| Minerva: Metadata for data discoverability and study replicability in observational studies L Gutierrez, R Gini, R Pajouheshnia, E Hyde, MA Swertz, M Sturkenboom, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 564-564, 2022 | | 2022 |
| Brodalumab assessment of hazards: A multinational safety (brahms) study of a biological anti-psoriatic drug across six European countries M Reilev, P Jensen, H Stovring, LS Ranch, R Gini, CC Bartolini, G Trifiro, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 487-488, 2022 | | 2022 |
| St John's Wort: Utilization during pregnancy and pregnancy outcomes W Schaefer, N Wentzell, U Haug PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 173-173, 2020 | | 2020 |
| Anticholinergic burden and fractures in older adults: Results from a methodological systematic review J Reinold, W Schaefer, L Christianson, F Barone-Adesi, O Riedel, FE Pisa PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 287-288, 2020 | | 2020 |
| Antidepressants and the Risk of Hemorrhagic Stroke W Schaefer, C Princk, N Schlie, B Kollhorst, T Schink PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 248-249, 2017 | | 2017 |
| Off-Label Antidepressant Use W Schaefer, B Kollhorst, T Reinders, O Riedel PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 465-466, 2017 | | 2017 |
| Does the socioeconomic status differ between users of potentially NDMA-contaminated generic valsartan and users of brand-name valsartan in Germany? Unterscheiden sich Nutzer … K Platzbecker, W Schäfer, U Haug | | |
